3 results match your criteria: "Switzerland (Institute of Primary Care).[Affiliation]"
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data.
Swiss Med Wkly
January 2021
Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Switzerland / Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.
Aims Of The Study: The prevalence of the use of valproate during pregnancy and by women of childbearing age in Switzerland is not known. We aimed to study the use of antiseizure drugs by these women in Switzerland, with a particular focus on valproate.
Methods: We conducted a retrospective descriptive study using the healthcare claims database of the Swiss health insurance Helsana (2014–18).
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit.
Swiss Med Wkly
September 2020
Swiss Hepatitis, Zurich, Switzerland.
Chest pain in an elite master ultra-marathon runner: a case report with a follow-up on his subsequent athletic activity.
Int J Occup Med Environ Health
June 2020
University of Zurich, Zurich, Switzerland (Institute of Primary Care).
Ultra-marathon running has enjoyed increasing popularity, with the number of master ultra-marathon runners growing annually. This study presents a case of a 51-year-old highly experienced long-distance runner (body mass: 65.1 kg, body height: 168 cm), who took part in a 48-h ultra-marathon race held in 2010, but dropped out of the competition due to acute cardiac problems manifested after 16 h of running and having completed a distance of 129 km.
View Article and Find Full Text PDF